Compare

Two terms, side by side

Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

Clinical & Trials

Pragmatic Trial

In one line

A trial designed to evaluate effectiveness in usual-care settings, using broad eligibility, routine workflows, and outcomes meaningful to patients and payers.

Definition

A pragmatic clinical trial is designed to evaluate effectiveness in everyday clinical practice rather than the controlled efficacy demonstrated in tightly designed explanatory trials. Pragmatic trials use broad eligibility, real-world clinical settings, flexible interventions delivered by routine providers, and patient-centered or claims-derived outcomes. The PRECIS-2 framework helps trial designers position a study along the explanatory-pragmatic continuum across nine domains.

Why it matters

Pragmatic trials are central to value-based care evidence generation and to MedTech post-market studies that support broader reimbursement.

Common pitfalls

•Confusing pragmatic with low-rigor — pragmatic trials still require pre-specified analysis and unbiased outcome ascertainment.
•Choosing claims data for outcomes without understanding coding lag and accuracy.

Sources

NIH Pragmatic Trials Collaboratory · NIH
PRECIS-2 · PRECIS-2
FDA - Clinical Trials and Human Subject Protection · FDA

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.